Transcatheter Patch Occlusion of Heart Defects

Catheterization and Cardiovascular Interventions

Volumn 61, Issue 1, 2004, Pages 150-151

  Sideris, Eleftherios B ^a   Moulopoulos, Spyridon D ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

NICKEL; NITINOL;

ALLERGY; ARTIFICIAL EMBOLISM; BALLOON; CONGENITAL HEART MALFORMATION; CORONARY ARTERY SPASM; DEVICE; ELECTRON MICROSCOPY; EROSION; FALLOT TETRALOGY; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART OUTPUT; HISTOPATHOLOGY; HUMAN; IMMOBILIZATION; IMPLANTATION; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LETTER; LUNG CANCER; MEDICAL DECISION MAKING; NONHUMAN; PATENT DUCTUS ARTERIOSUS; SAFETY;

ANIMALS; BALLOON OCCLUSION; BIOCOMPATIBLE MATERIALS; HEART CATHETERIZATION; HEART SEPTAL DEFECTS; HUMANS; MODELS, ANIMAL; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION; SWINE;

EID: 0346732098     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10719     Document Type: Letter

References (14)

1. Sideris EB, Sideris SE, Toumanides S, Moulopoulos SD. From disk devices to transcatheter patches: the evolution of wireless heart defect occlusion. J Interv Cardiol 2001;14:211-214.
2. Sideris EB, Toumanides S, Macuil B, Leonard H, Pursanov M, Sokolov A, Moulopoulos SD. Transcatheter patch occlusion of secundum atrial septal defects. Am J Cardiol 2002;89:1082-1086.
3. Lock JE, Rome JJ, Davis R, et al. Transcatheter closure of atrial septal defects: experimental studies. Circulation 1989:79:1091-1099.
4. Sideris EB, Sideris SE, Fowlkes JP et al. Transvenous atrial septal defect occlusion in piglets with a buttoned double disk device. Circulation 1990:81:312-318.
5. Jux C, Wohlsein P, Bruegmann M, et al. The evolving implant: a new biological matrix for septal occlusion. Circulation 2002;106(Suppl 2):486.
6. Prieto LR, Foreman CK, Cheatham JP, et al. Intermediate-term outcome of transcatheter secundum atrial septal defect closure, using the Bard clamshell septal occluder. Am J Cardiol 1996;78:1310-1312.
7. Lai MJ, Ryan CA, Gauvreau K, et al. Clinical, procedural, device and manufacturing variables associated with fracture occurrence in the CardioSEAL device. Circulation 1999;100;1803.
8. Hung J, Landzberg MJ, Jenkins KJ, King ME, Lock JE, Palacios IF, Lang P. Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol 2000;35:1311-1316.
9. Sievert H, Trapels T, Billinger K, et al. Catheter closure of atrial septal defects in adults with the Amplantzer occluder: acute and follow-up results in 178 concecutive patients. Circulation 2001:104(Suppl):2805.
10. Sievert H. Comment. Chicago: American Heart Association meeting: 2002.
11. Sunderman FW. A review of the metabolism and toxicology of nickel. Ann Clin Lab Sci 1977;7:377-398.
12. Ries M, Kampmann C, Meyer J. Nickel release in patients with atrial septal Defects after the implantation of the Amplantzer septal occluder. Circulation 2000:102(Suppl 2):767.
13. Sideris EB, Macuil B, Zhang J, Leonard C. Transcatheter perimembranous ventricular septal defect occlusion by wireless devices. Eur Heart J 2001;22(Suppl):2536.
14. Sideris EB, Rao PS, Macuil B, Varvarenko V, Zamora R. The adult with the giant patent ductus arteriosus: the transcatheter occlusion challenge. Circulation 2001;104(Suppl):2808.